Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

1,107 Cr

Lock In Period

N/A

Expense Ratio

2.27

Benchmark

BSE Healthcare Total Return

Exit Load

1% if less than 30 days, Nil if greater then or equals to 30 days.

Summary

Latest details for UTI Healthcare Fund Growth include a 274.512 NAV as of Mar 16,2026 and returns since inception of 96.51%. Minimum investments start at SIP ₹500. The UTI Healthcare Fund Growth AUM is ₹1,107 Cr, with a lock-in of N/A years, expense ratio of 2.27%, and benchmark BSE Healthcare Total Return. Exit load is - 1% if less than 30 days, Nil if greater then or equals to 30 days.. In the growth review for 1M Month/Year, the fund recorded -0.96% returns, against a category average of -1.29% and a category best of 2.53%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-0.96-1.292.53
6M-6.651.248.52
1Y8.276.2613.23
3Y25.2615.73112.80

Portfolio Analysis

  • Equity: 98.21%
  • Debt: 1.80%
  • Others
As on: 2026-02-28
View allocation % by

1. SUN PHARMACEUTICALS INDUSTRIES9.42%
2. AJANTA PHARMA LTD.7.04%
3. LUPIN LTD.5.79%
4. GLENMARK PHARMACEUTICALS LTD.4.25%
5. GLAND PHARMA LTD.3.54%
6. DIVIS LABORATORIES LTD.3.52%
7. DR REDDYS LABORATORIES LTD.3.48%
8. ALKEM LABORATORIES LTD3.47%
9. AUROBINDO PHARMA LTD.2.66%
10. COHANCE LIFESCIENCES LIMITED2.66%
11. CAPLIN POINT LABORATORIES LTD2.23%
12. PROCTOR & GAMBLE HEALTH LTD2.21%
13. SUDEEP PHARMA LIMITED2.19%
14. IPCA LABORATORIES LTD.2.17%
15. VIYASH SCIENTIFIC LTD2.11%
16. SAI LIFE SCIENCES LTD2.07%
17. ANTHEM BIOSCIENCES LTD1.91%
18. ERIS LIFESCIENCES LTD1.84%
19. CIPLA LTD.1.83%
20. PFIZER LIMITED1.77%
21. MARKSANS PHARMA LTD.1.65%
22. WINDLAS BIOTEC LTD1.13%
23. ACUTAAS CHEMICALS LIMITED1.07%
24. EMCURE PHARMACEUTICALS LTD0.94%
25. AARTI PHARMALABS LTD0.84%
26. JUBILANT PHARMOVA LIMITED0.70%
27. BIOCON LTD.0.70%
28. SYNGENE INTERNATIONAL LTD.0.69%
29. ORCHID PHARMA LTD.0.56%
30. ALEMBIC PHARMACEUTICALS0.52%

1. APOLLO HOSPITALS ENTERPRISE LT3.75%
2. FORTIS HEALTHCARE LTD.2.98%
3. MAX HEALTHCARE INSTITUTE LTD2.85%
4. JUPITER LIFE LINE HOSPITALS LTD2.06%
5. GLOBAL HEALTH LTD.2.02%
6. ASTER DM HEALTHCARE LTD1.94%
7. METROPOLIS HEALTHCARE LTD1.66%
8. KRISHNA INSTITUTE OF MEDI SCIE1.55%
9. DR LAL PATHLABS LTD.1.26%
10. VIJAYA DIAGNOSTIC CENTRE LTD1.09%
11. RAINBOW CHILDRENS MEDICARE LTD0.85%

About Fund

UTI Healthcare Fund Growth managed by UTI Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,107 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.27. Under the expert guidance of Kamal Gada ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Peer Comparison

Fund Name1Y3Y
This FundNippon India Pharma Fund Growth8.405589.5813
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth9.63691.2827
This FundMirae Asset Healthcare Fund Growth11.617995.538
This FundSBI Healthcare Opportunities Fund Growth5.798795.8042
This FundUTI Healthcare Fund Growth8.266696.5108

FAQs

UTI Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of UTI Healthcare Fund Growth is 2.27. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

UTI Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : -0.96%
  • 6 Months : -6.65%
  • 1 Year : 8.27%
  • 3 Years : 25.26%
Returns of UTI Healthcare Fund Growth are updated daily based on NAV of ₹ 274.512 as on Mar 16,2026. Since inception, the return has been 96.51%.

You can invest in UTI Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of UTI Healthcare Fund Growth is ₹1,107 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in UTI Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500